MSB 5.24% $1.11 mesoblast limited

In the current Covid situation and being a US company it may get...

  1. 136 Posts.
    lightbulb Created with Sketch. 25
    In the current Covid situation and being a US company it may get expedited through the trials. Considering how phase 3 of Ryoncil for Covid19 ARDS could be completed and approved for within 6-8 months, where normally a phase 3 would take years, If this is proven safe and it is effective as it is claimed who knows it may be approved for ARDS within a year. And if it is as potent as it is claimed it may be a preferred treatmebt fir ARDS over Ryoncil.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.